Updated: 2011-06-28 23:29:02
Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates
Updated: 2011-06-28 23:29:02
Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates
Updated: 2011-06-28 23:29:01
Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates
Updated: 2011-06-28 15:27:54
Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates
Updated: 2011-06-27 05:01:13
(Beyond Pesticides, June 27, 2011) A study published in the May 2011 edition of the journal Reproductive Toxicology finds pregnant women and their fetuses contaminated with pesticides and metabolites of the herbicide gluphosinate and the Cry1Ab protein of the insecticide based on the bacterium bacillus thuringiensis (Bt), both affiliated with genetically engineered (GE) food. The [...]
Updated: 2011-06-23 22:17:38
Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates
Updated: 2011-06-23 14:16:28
. Follow GEN : on Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates
Updated: 2011-06-23 07:47:03
Each time a cell divides its chromosome caps (called telomeres) get shorter. When telomeres get really short they interfere with the health of cells and cell division becomes more difficult. Telomere length is an indicator (albeit not perfect) of cell age and cell health. Therefore mechanisms by which telomere length impact cell health and cell death are as important topic of aging research. So it is interesting that NIH researchers have discovered a mechanism by which telomere shortening boosts production of the toxic protein progerin in cells. National Institutes of Health researchers have identified a new pathway that sets the clock for programmed aging in normal cells. The study provides insights about the interaction between a toxic protein called progerin...
Updated: 2011-06-21 08:40:03
An article in Technology Review about synthetic biology (e.g. create custom organism to make stuff) includes an interesting fact at the end: the costs of DNA synthesis is dropping as fast as the cost of DNA sequencing. Fortunately, the cost of DNA synthesis technology, much like that of DNA sequencing technology, is dropping rapidly. George Church, director of the Center for Computational Genomics at Harvard, noted in his talk that the costs of both DNA synthesis and sequencing technologies have been decreasing at an astonishing ratelately by a factor of 10 each year. The dropping costs for DNA synthesis will accelerate the rate at which scientists try out new designs of genes and organisms. Where does this lead in the...
Updated: 2011-06-17 05:01:57
(Beyond Pesticides, June 17, 2011) The U.S. House of Representatives this week approved a measure that would bar the Food and Drug Administration (FDA) from allowing genetically engineered (GE) salmon to be freely bought and sold. The measure was added as an amendment to the 2012 agriculture and food safety funding bill by U.S. Representative [...]
Updated: 2011-06-14 16:28:20
You are a mutant. Don't deny it. Accept your role in the mutant horde. Each one of us receives approximately 60 new mutations in our genome from our parents. This striking value is reported in the first-ever direct measure of new mutations coming from mother and father in whole human genomes published today. For the first time, researchers have been able to answer the questions: how many new mutations does a child have and did most of them come from mum or dad? The researchers measured directly the numbers of mutations in two families, using whole genome sequences from the 1000 Genomes Project. The results also reveal that human genomes, like all genomes, are changed by the forces of mutation:...
Updated: 2011-06-10 23:09:00
: FuturePundit Future technological trends and their likely effects on human society , politics and . evolution Lower Cost Nanodevices Go Read More Posts On FuturePundit June 10, 2011 DARP Wants Living Foundries Biological Factories The US Defense Advanced Research Projects Agency is looking to fund the development of scalable bio-factories where cells or materials normally found in cells will make assorted . products A recent call for research by the Pentagons mad science agency proposes a new program called Living Foundries . The idea is to use biology as a manufacturing platform to enable on-demand production of new and high-value materials , devices and capabilities . Click thru and read the . details Looks like we will get biological factories long before Eric Drexler's
Updated: 2011-06-07 01:29:42
Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-06-06 17:27:50
: Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
Updated: 2011-06-04 00:01:29
Biotechnology from bench to business Log In Register Subscribe BioBusiness GEN News Highlights StockWatch Analysis Insight Feature Articles Industry Updates Corporate Profiles BLOGbiotech Biomarket Trends Podcasts Wall Street Biobeat Webinars Events Drug Discovery GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events OMICS GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Bioprocessing GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products BLOGbiotech Podcasts Webinars Events Translational Medicine GEN News Highlights Feature Articles Analysis Insight Tutorials Industry Updates New Products
